Synfacts, Table of Contents

Synfacts 2023; 19(06): 0615
DOI: 10.1055/s-0042-1752682

Innovative Drug Discovery and Development

Discovery of a Selective pan-FGFR Inhibitor Approved for Treatment of Cholangiocarcinoma

Contributor(s):

Antonia F. Stepan (Roche)

,

Danica A. Rankic (Pfizer)